Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant calmette-Guerin bacillus vaccine for secretion of human interferon-alphaza and its constructing method

A technology for recombinant BCG and its construction method, which is applied in the field of recombinant BCG that secretes human interferon-α2a and its construction, to achieve the effects of improving drug efficacy, reducing the burden of medical expenses, and reducing medical expenses

Inactive Publication Date: 2005-12-21
SHANGHAI JIAO TONG UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the research on improving the curative effect of bladder tumor by constructing recombinant BCG capable of secreting IFN-α2a by means of genetic engineering technology has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant calmette-Guerin bacillus vaccine for secretion of human interferon-alphaza and its constructing method
  • Recombinant calmette-Guerin bacillus vaccine for secretion of human interferon-alphaza and its constructing method
  • Recombinant calmette-Guerin bacillus vaccine for secretion of human interferon-alphaza and its constructing method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Step 1 Construction of BCG Shuttle Expression Vector

[0033] 1. Synthesis of amplification primers

[0034]According to the gene sequences of Ag85B signal peptide and human IFN-α2a, the main secretion antigens of BCG, which are already available in GeneBank, the amplification primers for Ag85B signal peptide and IFN-α2a were designed, respectively.

[0035] Ag85B sense: 5′-GGATCCATGACAGACGTGAG-3′

[0036] antisense: 5′-CTGCCGTGCCGATCATCAAT-3′

[0037] IFN-α2a sense: 5′-AGCGAATTCTGTGATCTGCCTCAAACCCA-3′

[0038] antisense: 5′-AGCGTCGACTCATTCCTTACTTCTTAAACTTTCTTGC-3′

[0039] Sequencing primer on pMV261 vector: 5′-GACAACTTGAGCCGTCCGTC-3′

[0040] 2. Load the Ag85B signal peptide gene into the pMV261 vector

[0041] Synthesize the signal peptide gene and clone it into pUCm-T vector

[0042] Ligation (TAKARA) system: pUCm-T vector 1μl

[0043] Signal peptide fragment (about 50ng / μl) 4μl

[0044] Solμtion I 5μl ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Relative molecular massaaaaaaaaaa
Login to View More

Abstract

This invention involves reorganization BCG vaccine for secretion of people interferon- alpha2a, and structuring method. Utilize gene engineering to clone BCG vaccine Ag85B signal peptide part and the genes of people IFN - alpha 2a playing a secreting role to pMV261 to receive the BCG vaccine shuttling expression carrier pMSIFN - alpha 2a. Adopt electric boring technology to lead pMSIFN - alpha 2a into BCG to recombinate rBGGIFN - alpha2a. Depending on rBGGIFN - alpha 2a duplicating in BCG and the secretion function of the signal peptide, can secrete IFN - alpha2a efficiently.

Description

technical field [0001] The present invention relates to a recombinant BCG that secretes human interferon-α2a and its construction method, in particular to a recombinant BCG containing the main secretion antigen Ag85B signal peptide fragment of BCG and interferon-α2a (IFN-A 2A) and its construction method The obtained recombinant bacillus Calmette-Guerin rBCGIFN-α2a is used for preventing and treating superficial bladder tumors, and belongs to the technical field of genetic engineering. Background technique [0002] Since Morales first reported the application of Bacillus Calmette-Guerin (BCG) bladder infusion in the treatment of superficial bladder tumors in 1976, BCG as an effective immune adjuvant has achieved good results in the prevention and treatment of bladder tumors. One of the most effective adjuvant treatments for tumors. Although BCG has good efficacy in the prevention and treatment of superficial bladder tumors, there are still many problems to be solved. The f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/09
Inventor 刘海涛夏术阶孙晓文
Owner SHANGHAI JIAO TONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com